Contemporary Concise Review 2021: Interstitial lung disease.
Respirology
; 27(7): 539-548, 2022 07.
Article
in English
| MEDLINE | ID: covidwho-1832246
ABSTRACT
The last 2 years have presented previously unforeseen challenges in pulmonary medicine. Despite the significant impact of the SARS-CoV-2 pandemic on patients, clinicians and communities, advances in the care and understanding of interstitial lung disease (ILD) continued unabated. Recent studies have led to improved guidelines, better understanding of the role for antifibrotics in fibrosing ILDs, prognostic indicators and novel biomarkers. In this concise contemporary review, we summarize many of the important studies published in 2021, highlighting their relevance and impact to the management and knowledge of ILD.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Lung Diseases, Interstitial
/
Idiopathic Pulmonary Fibrosis
/
COVID-19
Type of study:
Diagnostic study
/
Observational study
/
Prognostic study
Limits:
Humans
Language:
English
Journal:
Respirology
Year:
2022
Document Type:
Article
Affiliation country:
Resp.14278
Similar
MEDLINE
...
LILACS
LIS